Temporal Characteristics of Device-Based Individual and Integrated Risk Metrics in Patients With Chronic Heart Failure

被引:9
|
作者
Zile, Michael R. [1 ,2 ,6 ]
Kahwash, Rami [3 ]
Sarkar, Shantanu [4 ]
Koehler, Jodi [4 ]
Butler, Javed [5 ]
机构
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[3] Ohio State Univ, Columbus, OH USA
[4] Medtronic, Minneapolis, MN USA
[5] Univ Mississippi, Jackson, MS USA
[6] Med Univ South Carolina, Dept Med, Div Cardiol, Room 323, 30 Courtenay Dr, Charleston, SC 29425 USA
关键词
KEY WORDS heart failure; hemodynamics; risk metrics; ATRIAL-FIBRILLATION; HOSPITALIZATION; READMISSION; DIAGNOSTICS; HF;
D O I
10.1016/j.jchf.2022.10.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Temporal characteristics of a multimetric risk score and its individual parameters before, during, and after a heart failure (HF) event have not been defined. OBJECTIVES A large real-world patient cohort with implantable cardioverter-defibrillators and cardiac resynchronization therapy (CRT) defibrillators was used to define these temporal characteristics. METHODS Deidentified health records were linked to manufacturer's device database in 17,886 patients. Multimetric risk score combined daily measures of impedance, heart rate, activity, heart rate variability, and atrial fibrillation (AF) burden, AF ventricular rate, CRT pacing, and ventricular tachycardia episodes and shocks. HF event was defined as an inpatient, emergency department, or observation unit stay with primary diagnosis of HF and intravenous diuretic agents administration. Changes in risk parameters during 60 days before, during, and after an HF event were compared in patients with no HF readmissions vs patients with HF readmission. RESULTS A total of 1,174 patients had HF events with no HF readmission, and 282 patients had HF events with HF readmission. Diagnostic risk score was higher on all 60 days before and after a HF event in patients with HF read-mission compared with patients with no readmission (P < 0.001). Change in risk score from admission to discharge was similar in patients with and without HF readmission, but the risk score fell more significantly 7 after discharge and 30 days after admission in patients without HF readmission (P < 0.001). CONCLUSIONS Temporal characteristics of risk metrics were significantly different in patients with no HF readmissions vs patients with HF readmission; patients without HF recurrence had larger recovery of risk metrics values toward normal. (J Am Coll Cardiol HF 2023;11:143-156) (c) 2023 by the American College of Cardiology Foundation.
引用
收藏
页码:143 / 156
页数:14
相关论文
共 50 条
  • [1] Updates on Device-Based Therapies for Patients with Heart Failure
    Al Danaf J.
    Butler J.
    Yehya A.
    Current Heart Failure Reports, 2018, 15 (2) : 53 - 60
  • [2] Weekly periodicity in device-based diagnostics in heart failure patients
    Verwey, HF
    Molhoek, SG
    Schatz, K
    van der Leden-Blaauw, S
    Froidcourt, K
    Schubert, B
    Schalij, MJ
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S195 - S195
  • [3] Device-based Activity Assessment In Chronic Heart Failure Patients Undergoing Synchronized Diaphragmatic Stimulation
    Arand, Patricia
    Bauer, Peter
    Cheng, Jack
    Harris, Gregg
    Fudim, Marat
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S52 - S52
  • [4] Device-based therapies for decompensated heart failure
    Brooksbank, Jeremy A.
    Albert, Chonyang
    CURRENT OPINION IN CARDIOLOGY, 2023, 38 (02) : 116 - 123
  • [5] Variability and correlation of device-based diagnostics in stable heart failure patients
    Verwey, HF
    Molhoek, SG
    Schatz, K
    Strrelaar, M
    Zeeuw, R
    Schubert, B
    Schalij, MJ
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S202 - S202
  • [6] Rates and reasons for device-based guideline eligibility in patients with heart failure
    Lyons, Kristin J.
    Podder, Mohua
    Ezekowitz, Justin A.
    HEART RHYTHM, 2014, 11 (11) : 1983 - 1990
  • [7] Interatrial Shunting, a Novel Device-Based Therapy for Patients With Heart Failure
    Yum, Brian K. W.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2018, 26 (05) : 267 - 273
  • [8] Therapeutic implications of implantable device-based monitoring of patients with heart failure
    Popjes E.
    Boehmer J.P.
    Current Treatment Options in Cardiovascular Medicine, 2008, 10 (5) : 371 - 379
  • [9] Plasmonic and electronic device-based integrated circuits and their characteristics
    Sakai, H.
    Okahisa, S.
    Nakayama, Y.
    Nakayama, K.
    Fukuhara, M.
    Kimura, Y.
    Ishii, Y.
    Fukuda, M.
    SOLID-STATE ELECTRONICS, 2016, 125 : 240 - 246
  • [10] Non-pharmacological therapy for chronic heart failure: Electrical device-based control
    Kasanuki, H
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S267 - S267